These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 17582802)

  • 1. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
    Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H
    Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers.
    Yokoyama Y; Xin B; Shigeto T; Mizunuma H
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1219-28. PubMed ID: 21681689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer.
    Shigeto T; Yokoyama Y; Xin B; Mizunuma H
    Oncol Rep; 2007 Oct; 18(4):833-40. PubMed ID: 17786343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor effect of non-steroidal anti-inflammatory drugs on human ovarian cancers.
    Xin B; Yokoyama Y; Shigeto T; Mizunuma H
    Pathol Oncol Res; 2007; 13(4):365-9. PubMed ID: 18158574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clofibric acid, a peroxisome proliferator-activated receptor alpha ligand, inhibits growth of human ovarian cancer.
    Yokoyama Y; Xin B; Shigeto T; Umemoto M; Kasai-Sakamoto A; Futagami M; Tsuchida S; Al-Mulla F; Mizunuma H
    Mol Cancer Ther; 2007 Apr; 6(4):1379-86. PubMed ID: 17431116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells.
    Hazra S; Dubinett SM
    Prostaglandins Leukot Essent Fatty Acids; 2007 Jul; 77(1):51-8. PubMed ID: 17697767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes.
    Naruse T; Nishida Y; Hosono K; Ishiguro N
    Carcinogenesis; 2006 Mar; 27(3):584-92. PubMed ID: 16219634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of lung tumors and their expression of cyclooxygenase-2 and peroxisome proliferator- activated receptor-gamma.
    Shaik MS; Chatterjee A; Singh M
    Clin Cancer Res; 2004 Feb; 10(4):1521-9. PubMed ID: 14977856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.
    Li J; Chen X; Dong X; Xu Z; Jiang H; Sun X
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1814-20. PubMed ID: 17074019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ciglitazone inhibits growth of lung cancer cells A549 in vitro and in vivo: an experimental study].
    Zhang HL; Zhang ZX; Xu YJ
    Zhonghua Zhong Liu Za Zhi; 2004 Sep; 26(9):531-4. PubMed ID: 15555282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model.
    Quintana R; Kopcow L; Marconi G; Young E; Yovanovich C; Paz DA
    Fertil Steril; 2008 Oct; 90(4 Suppl):1511-6. PubMed ID: 18166186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of a COX-2 inhibitor meloxicam on squamous cell carcinoma of the esophagus in vivo.
    Liu JF; Zhang SW; Jamieson GG; Zhu GJ; Wu TC; Zhu TN; Shan BE; Drew PA
    Int J Cancer; 2008 Apr; 122(7):1639-44. PubMed ID: 18058818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
    Kaplan J; Cook JA; O'Connor M; Zingarelli B
    Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice.
    Jiang X; Li H; Qiao H; Jiang H; Xu R; Sun X
    Cancer Sci; 2009 Nov; 100(11):2226-33. PubMed ID: 19709125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-gamma agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines.
    Yang YC; Tsao YP; Ho TC; Choung IP
    Int J Gynecol Cancer; 2007; 17(2):418-25. PubMed ID: 17316361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
    Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciglitazone enhances ovarian cancer cell death via inhibition of glucose transporter-1.
    Shin SJ; Kim JY; Kwon SY; Mun KC; Cho CH; Ha E
    Eur J Pharmacol; 2014 Nov; 743():17-23. PubMed ID: 25240713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone, a ligand for peroxisome proliferator-activated receptor-gamma acts as an inhibitor of colon cancer liver metastasis.
    Takano S; Kubota T; Nishibori H; Hasegawa H; Ishii Y; Nitori N; Ochiai H; Okabayashi K; Kitagawa Y; Watanabe M; Kitajima M
    Anticancer Res; 2008; 28(6A):3593-9. PubMed ID: 19189639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.